Related Experiment Video
Updated: Jan 21, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
Toll-like receptor 4: A promising therapeutic target for pneumonia caused by Gram-negative bacteria
Junying Ding1,2,3, Qingquan Liu1,2,3
1Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing, China.
Abstract:
Gram-negative bacteria (GNB) emerge as important pathogens causing pulmonary infection, which can develop into sepsis due to bacterial resistance to antibiotics. GNB pneumonia poses a huge social and economic burden all over the world. During GNB infection in the lung, Toll-like receptor 4 (TLR4) can form a complex with MD2 and CD14 after recognizing lipopolysaccharide of GNB, initiate the MyD88- and TRIF-dependent signalling pathways and stimulate host non-specific immune response. In this review, we summarize recent progress in our understanding of the role of TLR4 in GNB pneumonia. The latest experimental results, especially in TLR4 knockout animals, suggest a promising potential of targeting TLR4 signalling pathway for the treatment of GNB pneumonia. Furthermore, we highlight the benefits of Traditional Chinese Medicine as novel candidates for the therapy of GNB pneumonia due to the modulation of TLR4 signalling pathway. Finally, we discuss the promise and challenge in the development of TLR4-based drugs for GNB pneumonia.
Insights
Gram-negative bacterial pneumonia is a growing threat. Targeting Toll-like receptor 4 (TLR4) signaling shows promise for new treatments, including Traditional Chinese Medicine.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Gram-negative bacteria (GNB) cause severe pulmonary infections, leading to sepsis and antibiotic resistance.
- GNB pneumonia presents a significant global health and economic challenge.
- Toll-like receptor 4 (TLR4) recognizes GNB lipopolysaccharide, initiating immune signaling pathways.
Purpose of the Study:
- To review the role of TLR4 in GNB pneumonia.
- To explore potential therapeutic strategies targeting the TLR4 signaling pathway.
- To highlight Traditional Chinese Medicine as a novel treatment approach.
Main Methods:
- Review of recent experimental findings, including studies on TLR4 knockout animals.
- Analysis of TLR4-dependent signaling pathways (MyD88 and TRIF).
- Evaluation of Traditional Chinese Medicine's potential in modulating TLR4 signaling.
Main Results:
- TLR4 plays a critical role in the host immune response to GNB pneumonia.
- Targeting the TLR4 signaling pathway demonstrates therapeutic potential.
- Traditional Chinese Medicine components can modulate TLR4 signaling effectively.
Conclusions:
- Targeting TLR4 offers a promising strategy for treating GNB pneumonia.
- Traditional Chinese Medicine presents novel therapeutic candidates for GNB pneumonia.
- Further research is needed to develop TLR4-based drugs for GNB pneumonia.
More Related Videos
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Internal Receptors
G-protein Coupled Receptors
Negative Regulator Molecules

